A Biostatistics Primer with Evan Reynolds, PhD

One of the rising stars of the NeuroNetwork for Emerging Therapies, Dr. Evan Reynolds, gives a crash course on the use of biostatistics in our research.

What are biostatistics? And what do they have to do with the groundbreaking research at the NeuroNetwork for Emerging Therapies?

Watch Dr. Evan Reynold's Biostastics Primer:

The Longitudinal Determinants of Diabetic Complications in the Pima Indians of Arizona

The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese

Evan Reynolds, PhD

Postdoctoral Fellow

Lead Statistician

evanlr@med.umich.edu

Department of Neurology

1500 E Medical Center Dr

Ann Arbor MI 48109-0000

Brian Callaghan, MD, MS

Eva L. Feldman, MD, PhD, Professor of Neurology

Co-director, Neuromuscular Division

Associate Program Director, Neurology Residency

Director, Amyotrophic Lateral Sclerosis Clinic, VA Ann Arbor Health System, Ann Arbor, MI

bcallagh@med.umich.edu

Department of Neurology

4021 BSRB

Ann Arbor MI 48109-2200

Metabolic Neuropathy, Pain, Policy

Eva Feldman, MD, PhD

James W. Albers Distinguished University Professor of Neurology

Russell N. DeJong Professor of Neurology

Director, NeuroNetwork for Emerging Therapies

Director, ALS Center of Excellence